| Financial Year |
March 31 2023 |
| Monetary Funds |
5,377,251,277.14 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
308,404,488.87 |
| Accounts Receivable |
2,177,535,441.14 |
| Advances to Suppliers |
148,604,615.46 |
| Other Receivables |
86,390,573.60 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,469,166,741.96 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
62,211,852.65 |
| Total Current Assets |
11,001,936,415.16 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
148,738,562.57 |
| Investment Properties |
62,637,821.02 |
| Fixed Assetes |
5,400,809,261.68 |
| Under-construction Projects |
743,708,098.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
508,686,078.61 |
| R&D expenses |
235,484,798.75 |
| Goodwill |
160,151,939.27 |
| Long-Term Deferred and Prepaid Expenses |
23,093,791.30 |
| Deferred Income Tax Assets |
249,219,516.64 |
| Other Non-Current Assets |
109,934,317.89 |
| Sub-Total of Non-Current Assets |
7,956,035,761.12 |
| Total Assets |
18,957,972,176.28 |
| Short-Term Loans |
25,026,736.06 |
| Trading Financial liabilities |
-- |
| Notes Payable |
446,279,962.37 |
| Accounts Payable |
1,027,014,229.02 |
| Accounts Received In Advance |
3,537,659.85 |
| Employee Compensation Payable |
130,917,391.87 |
| Taxes Payable |
129,843,853.86 |
| Interest Payable |
-- |
| Dividend Payable |
2,768,777.56 |
| Other payables |
1,734,690,466.42 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
10,030,024.87 |
| Other Current Liabilities |
20,986,876.15 |
| Sub-Total of Current Liabilities |
3,676,011,507.07 |
| Long-term Loans |
-- |
| Bonds Payable |
2,537,771,406.49 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
118,897,415.86 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,855,008,184.88 |
| Total Liabilities |
6,531,019,691.95 |
| Paid-In Capital(Or Share Stock) |
1,172,086,348.00 |
| Capital Surplus |
3,587,417,590.59 |
| Surplus Reserve |
400,698,302.76 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
5,065,125,677.15 |
| Minority Stockholder's Interest |
1,942,314,638.91 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
10,484,637,845.42 |
| Owner's Equity（Stockholder's Equity） |
12,426,952,484.33 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
18,957,972,176.28 |
